Lung cancer remains the leading cause of cancer-related deaths in men and women, accounting for 1 in every 4 deaths caused by cancer in the United States. However, recent advances in immunotherapy, especially those called “immune checkpoint inhibitors,” bring new hope for patients with lung cancer.
Immune Checkpoint Inhibitors Offer New Hope for Patients with Lung Cancer
Several immune checkpoint inhibitors are now approved for patients with non–small-cell lung cancer, giving hope to patients living with this disease.
Last modified: January 4, 2019